In contrast, CHD1 deletion is mutually exclusive with PTEN loss or TMPRSS2:ERG fusion in human prostate tumors (14, 16, 25, 62), by crosstalk with key components in PTEN-AKT and AR signaling pathways. Here, AR is linked to prostate neoplasm.